- Home
- MBC vs ABCL Comparison
MBC vs ABCL Comparison
Compare MBC & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBC
- ABCL
- Stock Information
- Founded
- MBC 1954
- ABCL 2012
- Country
- MBC United States
- ABCL Canada
- Employees
- MBC N/A
- ABCL N/A
- Industry
- MBC Agricultural Chemicals
- ABCL Biotechnology: Pharmaceutical Preparations
- Sector
- MBC Industrials
- ABCL Health Care
- Exchange
- MBC Nasdaq
- ABCL Nasdaq
- Market Cap
- MBC 1.4B
- ABCL 1.1B
- IPO Year
- MBC N/A
- ABCL 2020
- Fundamental
- Price
- MBC $11.22
- ABCL $4.45
- Analyst Decision
- MBC Strong Buy
- ABCL Strong Buy
- Analyst Count
- MBC 1
- ABCL 5
- Target Price
- MBC $15.00
- ABCL $8.75
- AVG Volume (30 Days)
- MBC 965.4K
- ABCL 6.8M
- Earning Date
- MBC 08-06-2025
- ABCL 08-07-2025
- Dividend Yield
- MBC N/A
- ABCL N/A
- EPS Growth
- MBC N/A
- ABCL N/A
- EPS
- MBC 0.77
- ABCL N/A
- Revenue
- MBC $2,722,600,000.00
- ABCL $23,114,000.00
- Revenue This Year
- MBC N/A
- ABCL N/A
- Revenue Next Year
- MBC $4.37
- ABCL $71.11
- P/E Ratio
- MBC $14.84
- ABCL N/A
- Revenue Growth
- MBC 1.30
- ABCL N/A
- 52 Week Low
- MBC $9.63
- ABCL $1.89
- 52 Week High
- MBC $20.67
- ABCL $4.70
- Technical
- Relative Strength Index (RSI)
- MBC 53.77
- ABCL 59.22
- Support Level
- MBC $11.02
- ABCL $3.87
- Resistance Level
- MBC $11.52
- ABCL $4.13
- Average True Range (ATR)
- MBC 0.46
- ABCL 0.30
- MACD
- MBC -0.02
- ABCL -0.04
- Stochastic Oscillator
- MBC 44.00
- ABCL 59.32
About MBC MasterBrand Inc.
MasterBrand Inc operates as a residential cabinet manufacturer in North America. It offers a comprehensive portfolio of residential cabinetry products for the kitchen, bathroom, and other parts of the home. The firm sells its products throughout the United States and Canada through three primary channels: dealers, retailers and builders.
About ABCL AbCellera Biologics Inc.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.